英国癌症研究中心投资1400万英镑在伦敦建立癌症生物治疗中心

2018-09-18 MedSci MedSci原创

英国癌症研究中心将投资1400万英镑,将伦敦市建设为"世界领先的癌症生物治疗中心"。

英国癌症研究中心将投资1400万英镑,将伦敦市建设为"世界领先的癌症生物治疗中心"。

新的伦敦肿瘤研究中心将汇集伦敦大学学院、伦敦大学国王学院、伦敦玛丽皇后学院和弗朗西斯克里克研究所的研究人员,开展生物治疗药物领域的先驱研究。

伦敦大学学院中心负责人Tariq Enver教授说:"生物治疗药物已经取得了巨大进步,其中很多都来自我们的研究中心。这些药物很多具有很大的潜力,可以帮助我们应对最难治疗癌症,如脑肿瘤和肺癌。"

"该中心的建立将刺激伦敦市生物技术相关的经济活动,包括成立新公司,并且促进行业合作伙伴迁入伦敦将潜在药物进行转化。伦敦的医院也将成为新型生物疗法的评价中心,为全世界的医疗服务者树立新标准。"

英国癌症研究中心研究和创新执行主任Iain Foulkes博士说:"我们的投资代表了对伦敦在全球生物医学研究核心地位的认可,也相信该中心将为该市的市民、企业和医院带来巨大利益。"

新中心将聚集各个合作机构的专业人才,包括成像、临床试验和肿瘤治疗方面的专家。研究将涵盖所有癌症类型,包括对儿童癌症的关注。另外,新中心还提供了多种新的合作和培训机会。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=346799, encodeId=c0bc346e996c, content=大手笔,希望能有进展, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8e425737, createdName=tw007007, createdTime=Wed Sep 26 16:55:21 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514186, encodeId=49d41514186ca, content=<a href='/topic/show?id=448ee1455a3' target=_blank style='color:#2F92EE;'>#癌症研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71455, encryptionId=448ee1455a3, topicName=癌症研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c410636799, createdName=小华子, createdTime=Thu Sep 20 11:16:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623577, encodeId=415216235e7fe, content=<a href='/topic/show?id=dd898e10879' target=_blank style='color:#2F92EE;'>#英国癌症研究中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87108, encryptionId=dd898e10879, topicName=英国癌症研究中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f6b20558327, createdName=yankaienglish, createdTime=Thu Sep 20 11:16:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=345552, encodeId=114134555217, content=继续加大投入, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Sep 18 21:28:00 CST 2018, time=2018-09-18, status=1, ipAttribution=)]
    2018-09-26 tw007007

    大手笔,希望能有进展

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=346799, encodeId=c0bc346e996c, content=大手笔,希望能有进展, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8e425737, createdName=tw007007, createdTime=Wed Sep 26 16:55:21 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514186, encodeId=49d41514186ca, content=<a href='/topic/show?id=448ee1455a3' target=_blank style='color:#2F92EE;'>#癌症研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71455, encryptionId=448ee1455a3, topicName=癌症研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c410636799, createdName=小华子, createdTime=Thu Sep 20 11:16:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623577, encodeId=415216235e7fe, content=<a href='/topic/show?id=dd898e10879' target=_blank style='color:#2F92EE;'>#英国癌症研究中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87108, encryptionId=dd898e10879, topicName=英国癌症研究中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f6b20558327, createdName=yankaienglish, createdTime=Thu Sep 20 11:16:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=345552, encodeId=114134555217, content=继续加大投入, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Sep 18 21:28:00 CST 2018, time=2018-09-18, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=346799, encodeId=c0bc346e996c, content=大手笔,希望能有进展, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8e425737, createdName=tw007007, createdTime=Wed Sep 26 16:55:21 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514186, encodeId=49d41514186ca, content=<a href='/topic/show?id=448ee1455a3' target=_blank style='color:#2F92EE;'>#癌症研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71455, encryptionId=448ee1455a3, topicName=癌症研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c410636799, createdName=小华子, createdTime=Thu Sep 20 11:16:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623577, encodeId=415216235e7fe, content=<a href='/topic/show?id=dd898e10879' target=_blank style='color:#2F92EE;'>#英国癌症研究中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87108, encryptionId=dd898e10879, topicName=英国癌症研究中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f6b20558327, createdName=yankaienglish, createdTime=Thu Sep 20 11:16:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=345552, encodeId=114134555217, content=继续加大投入, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Sep 18 21:28:00 CST 2018, time=2018-09-18, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=346799, encodeId=c0bc346e996c, content=大手笔,希望能有进展, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c8e425737, createdName=tw007007, createdTime=Wed Sep 26 16:55:21 CST 2018, time=2018-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1514186, encodeId=49d41514186ca, content=<a href='/topic/show?id=448ee1455a3' target=_blank style='color:#2F92EE;'>#癌症研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71455, encryptionId=448ee1455a3, topicName=癌症研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42c410636799, createdName=小华子, createdTime=Thu Sep 20 11:16:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623577, encodeId=415216235e7fe, content=<a href='/topic/show?id=dd898e10879' target=_blank style='color:#2F92EE;'>#英国癌症研究中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87108, encryptionId=dd898e10879, topicName=英国癌症研究中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f6b20558327, createdName=yankaienglish, createdTime=Thu Sep 20 11:16:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=345552, encodeId=114134555217, content=继续加大投入, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Sep 18 21:28:00 CST 2018, time=2018-09-18, status=1, ipAttribution=)]
    2018-09-18 医者仁心5538

    继续加大投入

    0

相关资讯

Gut:重磅!伦敦癌症研究中心科学家找到食管癌的软肋,有望拯救近半数的食管癌患者

8月22日,来自伦敦癌症研究所Christopher Lord教授的科研团队在胃肠病领域顶级期刊《Gut》杂志上刊登了一项关于食管癌治疗的突破性发现(1),他们可能找到了食管癌的软肋。